Ro-CHOP

Comparaison de l’association Romidepsine-CHOP versus CHOP en première ligne chez des patients atteints d’un Lymphome T périphérique (phase III)

Suivi Long Terme

SLT

Publications 2022

Lysa 2022_LYSA_Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Emmanuel Bachy; Vincent Camus; Catherine Thieblemont; David Sibon; René-Olivier Casasnovas; Loïc Ysebaert; Gandhi Damaj; Stéphanie Guidez; Gian Matteo Pica; Won Seog Kim; Soon Thye Lim; Marc André; Alejandro Martín García-Sancho; Maria Jesus Penarrubia; Philipp B. Staber; Judith Trotman; Andreas Hüttmann; Vittorio Stefoni; Alessandro Re; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Michel Meignan; Ju Li; Franck Morschhauser; and Richard Delarue

J Clin Oncol . 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. En savoir plus